Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Cornea. 2018 Jul;37(7):893–898. doi: 10.1097/ICO.0000000000001491

Table 1.

Demographics, comorbidities, and medications of the study population (n=86)

Demographics
Age, mean (SD) 71 (8.6)
Gender, n (%) male 82 (95%)
Race, n (%) white 58 (67%)
Ethnicity, n (%) Non-Hispanic 69 (80%)
Co-morbidities
Diabetes Mellitus, n (%) 32 (37%)
Depression, n (%) 22 (26%)
Post-traumatic stress disorder, n (%) 12 (14%)
Sleep apnea, n (%) 20 (23%)
Non-ocular pain (headache, migraine, low back pain, fibromyalgia), n (%) 24 (28%)
Glaucoma, n (%) 12 (14%)
Medications
Anti-depressant, n (%) 26 (30%)
Anxiolytic, n (%) 11 (13%)
Antihistamine, n (%) 17 (20%)
Artificial Tears, n (%) 39 (45%)
Glaucoma medications, n (%) 6 (7%)

SD=standard deviation